Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment

Background: Ovarian cancer is the deadliest gynecologic malignancy despite current first-line treatment with a platinum and taxane doublet. Artesunate has broad antineoplastic properties but has not been investigated in combination with carboplatin and paclitaxel for ovarian cancer treatment. Method...

Descripción completa

Detalles Bibliográficos
Autores principales: McDowell, Anthony, Hill, Kristen S., McCorkle, Joseph Robert, Gorski, Justin, Zhang, Yilin, Salahudeen, Ameen A., Ueland, Fred, Kolesar, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996621/
https://www.ncbi.nlm.nih.gov/pubmed/33652561
http://dx.doi.org/10.3390/diagnostics11030395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996621/
https://www.ncbi.nlm.nih.gov/pubmed/33652561
http://dx.doi.org/10.3390/diagnostics11030395

Ejemplares similares